STRS Ohio’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,355
| Closed | -$970K | – | 2336 |
|
|
2025
Q1 | $970K | Sell |
7,355
-5,355
| -42% | -$667K | ﹤0.01% | 885 |
|
|
2024
Q4 | $1.06M | Sell |
12,710
-4,089
| -24% | -$336K | ﹤0.01% | 834 |
|
|
2024
Q3 | $1.23M | Buy |
16,799
+846
| +5% | +$63.6K | ﹤0.01% | 834 |
|
|
2024
Q2 | $1.09M | Sell |
15,953
-7,847
| -33% | -$544K | ﹤0.01% | 843 |
|
|
2024
Q1 | $1.65M | Sell |
23,800
-2,500
| -10% | -$172K | 0.01% | 718 |
|
|
2023
Q4 | $1.88M | Sell |
26,300
-1,600
| -6% | -$92K | 0.01% | 634 |
|
|
2023
Q3 | $1.45M | Buy |
27,900
+900
| +3% | +$52.4K | 0.01% | 740 |
|
|
2023
Q2 | $1.71M | Buy |
27,000
+6,300
| +30% | +$393K | 0.01% | 688 |
|
|
2023
Q1 | $1.12M | Sell |
20,700
-900
| -4% | -$43.5K | ﹤0.01% | 888 |
|
|
2022
Q4 | $1.14M | Sell |
21,600
-9,300
| -30% | -$466K | 0.01% | 884 |
|
|
2022
Q3 | $1.44M | Hold |
30,900
| – | – | 0.01% | 711 |
|
|
2022
Q2 | $1.76M | Buy |
30,900
+18,000
| +140% | +$1.02M | 0.01% | 649 |
|
|
2022
Q1 | $789K | Buy |
12,900
+4,600
| +55% | +$239K | ﹤0.01% | 1186 |
|
|
2021
Q4 | $434K | Buy |
8,300
+900
| +12% | +$37.8K | ﹤0.01% | 1524 |
|
|
2021
Q3 | $275K | Hold |
7,400
| – | – | ﹤0.01% | 1688 |
|
|
2021
Q2 | $302K | Buy |
+7,400
| New | +$274K | ﹤0.01% | 1717 |
|
|
2020
Q4 | – | Sell |
-2,900
| Closed | -$74K | – | 2300 |
|
|
2020
Q3 | $74K | Sell |
2,900
-2,000
| -41% | -$45.6K | ﹤0.01% | 1904 |
|
|
2020
Q2 | $125K | Buy |
+4,900
| New | +$99.2K | ﹤0.01% | 1746 |
|
|
2014
Q4 | – | Sell |
-2,370
| Closed | -$32K | – | 1817 |
|
|
2014
Q3 | $32K | Buy |
+2,370
| New | +$35.6K | ﹤0.01% | 1699 |
|
Other funds holding ITCI
STRS Ohio's ITCI Position: Q2 2025 in Review
STRS Ohio sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 7,355 shares — an estimated $970K sold.
STRS Ohio first reported a position in ITCI in Q3 2014 and held it in 19 quarters. The position peaked at $1.88M in Q4 2023. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- STRS Ohio reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- STRS Ohio sold 7,355 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $970K.
- STRS Ohio first reported a position in Intra-Cellular Therapies Inc. in Q3 2014 and held it in 19 quarters.
- STRS Ohio's Intra-Cellular Therapies Inc. position peaked at $1.88M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.